The Valley Desk

NCT01896999 · Interventional trial

Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma

Overall registry status Active not recruiting

Phase 1 · Phase 2

Conditions Recurrent Classic Hodgkin Lymphoma, Refractory Classic Hodgkin Lymphoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov